-

KARL STORZ Confirms Continuation of Operations

Pledges Uninterrupted Support to Healthcare Facilities Affected by COVID-19

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ Endoscopy-America, Inc., a leader in minimally invasive surgical technology with headquarters in Southern California, confirms that it will continue to provide vital support to healthcare facilities and providers across the country.

The state and local governments of California have taken extraordinary steps to curb the spread of COVID-19. On March 19, Governor Gavin Newsom directed all Californians to stay at home, while Los Angeles Mayor Eric Garcetti issued an emergency order closing nonessential businesses and prohibiting gatherings of more than 10 people in enclosed spaces.

The policies allow for “essential” businesses that are critical to providing healthcare and other infrastructure services to remain in operation. Countless health systems rely on KARL STORZ every day to deliver quality care to their patients, and KARL STORZ represents an “essential” component of the healthcare delivery ecosystem. As such, KARL STORZ will continue to provide vital products and services.

KARL STORZ is well positioned to assist healthcare providers through this difficult period, and began developing contingency plans long before the need to do so became clear. These plans included numerous changes to the office environment as well as vital IT upgrades to expand network connectivity and bandwidth. As a result, the corporate offices will be able to accommodate a minimal crew providing essential services and support. All other staff members will continue to work effectively from home. Our supply chain has not been disrupted so far, and we remain in close contact with our production sites in the US and Europe as well as with our supply chain partners. We are continuously evaluating the situation in order to secure our supply availability. Healthcare providers can be assured of comprehensive support, and are encouraged to remain in contact with their usual KARL STORZ representatives.

The situation concerning COVID-19 remains fluid, with new circumstances prompting new health policy directives seemingly every day; KARL STORZ will continue to monitor the situation and provide further guidance as appropriate.

About KARL STORZ

KARL STORZ Endoscopy-America, Inc., is an affiliate of KARL STORZ SE & Co. KG, an international leader for 75 years in reusable endoscope technology, providing surgical and procedural imaging, instrumentation, and enterprise-wide integration. Based in Tuttlingen, Germany, KARL STORZ SE & Co. KG is a family-owned company that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, call (800) 421-0837 or visit the company’s website at www.karlstorz.com.

Contacts

Susan Jaffy Marx
Marketing Communications
KARL STORZ Endoscopy-America, Inc.
(424) 218-8701

KARL STORZ Endoscopy-America, Inc.


Release Versions

Contacts

Susan Jaffy Marx
Marketing Communications
KARL STORZ Endoscopy-America, Inc.
(424) 218-8701

More News From KARL STORZ Endoscopy-America, Inc.

ADDING MULTIMEDIA KARL STORZ Announces FDA Clearance for ENDOFLATOR + Insufflator and Smoke Evacuation System

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in minimally invasive surgical technology, is proud to announce it has received U.S. Food and Drug Administration (FDA) clearance for the ENDOFLATOR™ +. ENDOFLATOR + is the next-generation insufflator with integrated surgical smoke evacuation system designed to meet the evolving needs of modern operating rooms. Using carbon dioxide gas, an insufflator establishes and maintains a stable working cavity within the body during laparos...

KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai. Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development,...

AventaMed, a KARL STORZ Company, Receives Expanded Indication for Solo+ Tympanostomy Tube Device (TTD)

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ United States is proud to announce that the US Food and Drug Administration (FDA) has cleared an expanded indication for the AventaMed Solo+™ Tympanostomy Tube Device (TTD), allowing its use in pediatric patients aged 6 months and older. This expanded clearance builds on the previous 510(k) clearance, which was indicated for patients 6 to 24 months old. The Solo+ device represents a significant advancement in pediatric ENT care. It is intended to...
Back to Newsroom